TEVA - Teva Pharmaceutical Industries Limited

NYSE - Nasdaq Real Time Price. Currency in USD
8.44
-0.12 (-1.38%)
As of 12:18PM EDT. Market open.
Stock chart is not supported by your current browser
Previous Close8.56
Open8.52
Bid8.48 x 4000
Ask8.49 x 900
Day's Range8.41 - 8.59
52 Week Range7.96 - 25.96
Volume4,923,820
Avg. Volume17,871,550
Market Cap9.102B
Beta (3Y Monthly)2.46
PE Ratio (TTM)N/A
EPS (TTM)-3.42
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend Date2017-11-27
1y Target Est14.27
Trade prices are not sourced from all markets
  • Zacks2 hours ago

    J&J (JNJ) Beats on Q2 Earnings, Ups 2019 Sales Growth View

    J&J (JNJ) beats estimates for both earnings and sales in the second quarter of 2019 and raises 2019 guidance for operational sales growth for the second time this year.

  • GlobeNewswire2 hours ago

    INVESTOR ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Teva Pharmaceutical Industries Ltd. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

    The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Teva Pharmaceutical Industries Ltd. (“Teva” or “the Company”) (NYSE: TEVA) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. You can also reach us through the firm's website at www.schallfirm.com, or by email at brian@schallfirm.com.

  • GlobeNewswire3 hours ago

    CLASS ACTION UPDATE for BUD, TEVA, EQT and INS: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

    NEW YORK, July 16, 2019 -- Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies..

  • GlobeNewswire13 hours ago

    SHAREHOLDER ALERT: CLAIMSFILER REMINDS BUD, EROS, TEVA INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits

    NEW ORLEANS, July 15, 2019 -- ClaimsFiler, a FREE shareholder information service, reminds investors of pending deadlines in the following securities class action lawsuits:.

  • Teva Pharmaceuticals News: Why TEVA Stock Is Sliding Today
    InvestorPlace20 hours ago

    Teva Pharmaceuticals News: Why TEVA Stock Is Sliding Today

    Teva Pharmaceuticals (NYSE:TEVA) is having a Monday of nightmares as some of the company's products have led to lawsuits, which brought about a major analyst downgrade, causing TEVA stock to plummet early in the week.Source: Shutterstock The Israel-based pharma business with a global reach suffered today as the company's opioid-linked litigation has only started to kick off, with thousands of new lawsuits on the horizon. The harmful painkillers recently led to a judge giving the green light for an $85 million settlement in the state of Oklahoma, ensuring that the company will not promote opioids in the state.This is only the tip of the iceberg for Teva, which had a Monday that saw Morgan Stanley lower the stock's rating from an Equal Weight to an Underweight. The firm added that its price target on TEVA stock has now decreased from $16 per share to $6 per share.InvestorPlace - Stock Market News, Stock Advice & Trading TipsMorgan Stanley analyst David Risinger noted that the pharmaceutical giant, as well as competitors such as Endo International PLC (NASDAQ:ENDP), are experiencing "underappreciated risks" coming from buying group pressure, which are now more negative than predicted.These include a rise in generic competition, as well as the aforementioned opioid-related suits. The note arrived soon after Argus Capital upped its rating on TEVA stock to a buy with a $12 price target on July 5, 2019.TEVA stock fell 7.5% by day's end, while ENDO stock slid 3.7%. More From InvestorPlace * 10 Best Dividend Stocks to Buy for the Rest of 2019 and Beyond * 7 Dependable Dividend Stocks to Buy * 7 Retail Stocks to Buy for the Second Half of 2019 * 10 Stocks to Sell for an Economic Slowdown The post Teva Pharmaceuticals News: Why TEVA Stock Is Sliding Today appeared first on InvestorPlace.

  • Why Callon Petroleum, Teva Pharmaceutical Industries, and PG&E Slumped Today
    Motley Fool20 hours ago

    Why Callon Petroleum, Teva Pharmaceutical Industries, and PG&E Slumped Today

    The indexes didn't make major moves today, but these stocks did.

  • Reuters23 hours ago

    UPDATE 4-Opioid 'kingpin' J&J fueled epidemic, Oklahoma argues at trial's end

    Lawyers for the state of Oklahoma on Monday compared Johnson & Johnson to a drug cartel leader as they sought to hold the drugmaker responsible for fueling the U.S. opioid epidemic in the first trial to result from lawsuits over the crisis. Lawyers for the state, including Attorney General Mike Hunter, told a judge in Norman, Oklahoma that J&J's "greed" led the drugmaker to carry out a years-long marketing effort that caused "utter confusion" about the addictive painkillers' risks. Brad Beckworth, a lawyer for the state, said J&J knew opioids were harmful, yet minimized the risk of addiction in their marketing, resulting in a surge in overdose deaths as doctors overprescribed the drugs and they flooded the state.

  • Teva Relief Rally Loses Steam After Analyst Downgrade
    Investopediayesterday

    Teva Relief Rally Loses Steam After Analyst Downgrade

    Teva Pharmaceutical shares moved lower after Morgan Stanley downgraded the stock to Underweight with a price target of $6 per share.

  • ACCESSWIREyesterday

    The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of ASNA, BUD and TEVA

    NEW YORK, NY / ACCESSWIRE / July 15, 2019 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.

  • Benzingayesterday

    Morgan Stanley Downgrades Teva, Endo On Drug Pricing And Litigation Concerns

    Pharmaceutical stocks have been under pressure for the past few trading days, but one Wall Street analyst said the worst is yet to come for a handful of specialty drugmakers. The Analyst Morgan Stanley ...

  • ACCESSWIREyesterday

    Class Action Reminder - ASNA, BUD & TEVA - Bronstein, Gewirtz & Grossman, LLC

    NEW YORK, NY / ACCESSWIRE / July 15, 2019 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed againstthe following publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you may contact Peretz Bronstein, Esq. If you suffered a loss, you can request that the Court appoint you as lead plaintiff.

  • Barrons.comyesterday

    Teva and Endo Stock Are Falling Because Opioid Suits Aren’t Going Away

    The two generic drugmakers were down Monday morning, with Teva getting the worse of it, after a Morgan Stanley analyst downgraded them both, citing the ongoing litigation over prescription opioid sales.

  • Business Wireyesterday

    Teva Announces FDA Approval of AirDuo® Digihaler™ (fluticasone propionate 113 mcg and salmeterol 14 mcg) Inhalation Powder

    Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that the U.S. Food and Drug Administration (FDA) has approved AirDuo® Digihaler™ (fluticasone propionate 113 mcg and salmeterol 14 mcg) Inhalation Powder, a combination therapy digital inhaler with built-in sensors that connects to a companion mobile application to provide information on inhaler use to people with asthma. AirDuo® Digihaler™ is indicated for the treatment of asthma in patients aged 12 years and older.

  • Reutersyesterday

    Oklahoma, J&J to wrap up first trial over opioid crisis

    Oklahoma's attorney general is expected on Monday to urge a judge to find Johnson & Johnson responsible for flooding the market with painkillers and fueling the U.S. opioid epidemic, as the first trial in nationwide litigation over the drug crisis comes to an end. Lawyers for Attorney General Mike Hunter and J&J are set to deliver closing arguments in state court in Norman, Oklahoma following six weeks of testimony from current and former J&J executives and victims of the epidemic. The Oklahoma case is being closely watched by plaintiffs in other opioid lawsuits, particularly in 1,900 cases pending in Ohio brought largely by cities and counties against J&J and other companies.

  • TheStreet.comyesterday

    [video]Teva Shares Slump on Opioid Litigation Risk Downgrade From Morgan Stanley

    Shares of Teva Pharmaceuticals fall after the company receives a downgrade from Morgan Stanley amid heightened "litigation risks" related to its involvement in the opioid crisis.

  • ACCESSWIRE2 days ago

    SHAREHOLDER ALERT: PSMT TEVA FDX: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

    NEW YORK, NY / ACCESSWIRE / July 14, 2019 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of shareholders of the following companies. If you suffered a loss you have ...

  • GlobeNewswire3 days ago

    SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS BUD, EROS, PSMT, TEVA INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits

    NEW ORLEANS, July 12, 2019 -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors of pending.

  • ACCESSWIRE4 days ago

    The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of PYX, TEVA and FDX

    NEW YORK, NY / ACCESSWIRE / July 12, 2019 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a loss you have ...

  • GlobeNewswire4 days ago

    ASNA,  BUD & TEVA - Bronstein, Gewirtz & Grossman, LLC Class Action Announcement

    Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you may contact Peretz Bronstein, Esq. If you suffered a loss, you can request that the Court appoint you as lead plaintiff.  Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

  • Teva buys three buildings in West Chester for its R&D campus
    American City Business Journals4 days ago

    Teva buys three buildings in West Chester for its R&D campus

    Teva Pharmaceuticals USA bought three buildings in West Chester this week that — together with three other adjacent buildings it already owns — will allow the pharmaceutical manufacturer to “firmly establish” a North America research and development campus in Chester County. About 650 employees will be based at Teva in West Chester by the end of 2019, including teams involved in product and device research and development, regulatory affairs, medical affairs and a variety of support functions.

  • ACCESSWIRE4 days ago

    CLASS ACTION UPDATE for MBNKF, MOMO and TEVA: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

    NEW YORK, NY / ACCESSWIRE / July 12, 2019 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders ...

  • ACCESSWIRE4 days ago

    ASNA, BUD & TEVA - Bronstein, Gewirtz & Grossman, LLC Class Action Update

    NEW YORK, NY / ACCESSWIRE / July 12, 2019 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed againstthe following publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you may contact Peretz Bronstein, Esq. If you suffered a loss, you can request that the Court appoint you as lead plaintiff.

  • 3 Top Value Stocks to Buy in July
    Motley Fool4 days ago

    3 Top Value Stocks to Buy in July

    Looking for a bargain? We've got a few.

  • Amneal (AMRX) Down on Guidance Update & Restructuring Plan
    Zacks5 days ago

    Amneal (AMRX) Down on Guidance Update & Restructuring Plan

    Amneal (AMRX) slumps on news of budget cut and reduction in annual guidance.

  • GlobeNewswire5 days ago

    SHAREHOLDER ALERT: TUSK ASNA ZUO TEVA: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

    NEW YORK, July 11, 2019 -- The Law Offices of Vincent Wong announce that class actions have commenced on behalf of shareholders of the following companies. If you suffered a.